The page is the record's research on the issuer — no analyst, no rating, no view. # Iambic Therapeutics, Inc. (NASDAQ: IAM) — research page As of 2026-11-08 · us-cm-kg · record version 1 ## Identity and listing The issuer is Iambic Therapeutics, Inc., listed on NASDAQ under ticker IAM, incorporated in Delaware, United States. The ISIN is not on the record. The LEI is not on the record. The security type is recorded as non-operating entity type (other). The segment is not on the record. The sector is 2836 Biological Products, (No Diagnostic Substances). The issuer is listed and not halted. ## The disclosure read The record holds 42 filings in the twelve months to 2026-11-08, across 12 filing days. The filings comprise 1 corporate news, 29 directors' dealings, 3 prospectus and 9 regulatory filings. The median gap between filing days is 12 days. The latest filing is dated 2026-10-19 and is a directors' dealings filing, 20 days before the record date. On NASDAQ the median cadence gap is 6.0 days, the median filings count is 52 and the median latency is 5.0 days. In the sector the median cadence gap is 5.5 days, the median filings count is 65.5 and the median latency is 4.0 days. ## Auditor The auditor is not on the record, because the latest annual report cover carries no auditor name tag. The auditor's location is not on the record. The record holds no auditor changes. ## Events and halts The record holds listing lines dated 2026-10-13 and 2026-10-14. It holds no delisting, no name change and no segment move, and the domicile change is not on the record. The issuer is listed and not halted. ## Orderability The outcome is not determinable, because the chapter's orderability section names no client category. The rule version is acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1, and the chapter is as of 2026-11-04. ## Coverage The issuer's investor-relations page names no research houses, and none was found on the pages read. ## Open research No openly published research notes are on the record. ## Licensed Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded. ## As-of depth The sealed years that hold the issuer are 2023, 2024, 2025 and 2026. The market's earliest sealed date is 2021-01-04. The live record began on 2026-09-12. ## Sources 6 source pages are named on this page; every value above carries its own source page and read date in the numbers. - https://www.sec.gov/files/company_tickers_exchange.json (identity.exchange) - https://data.sec.gov/submissions/CIK0001997038.json (identity.jurisdiction) - https://mcp.us-cm-kg.ai/events/NASDAQ/IAM (the disclosure lines) - https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts (the halt flag) - https://mcp.us-cm-kg.ai/book/aio.json (the orderability chapter) - https://mcp.us-cm-kg.ai/record/NASDAQ/IAM (the record) --- Allooloo Technologies Corp. · https://getresearch.ai/us/NASDAQ/IAM · public-record only · the same page signed and receipted: get_research at https://mcp.getresearch.ai/mcp